Mark C. Enright

Corporate Officer/Principal bei Imperial College London

Health Technology

Consumer Services

Aktive Positionen von Mark C. Enright

Unternehmen	Position	Beginn	Ende
Imperial College London	Corporate Officer/Principal	31.10.2011	-

Unternehmen	Position	Beginn	Ende
Biocontrol Ltd. (United Kingdom) Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom.	Technik-/Wissenschafts-/F&E-Leiter	31.10.2011	-
AmpliPhi Biosciences Corp. AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.	Technik-/Wissenschafts-/F&E-Leiter	31.10.2011	-

University of Aberdeen

Doctorate Degree

International

Vereinigtes Königreich	4
Vereinigte Staaten	2

Operativ

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	3
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
AmpliPhi Biosciences Corp. AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.	Health Technology
Biocontrol Ltd. (United Kingdom) Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom.	Health Technology

Private Unternehmen

Health Technology